Passa al contenuto
Merck
Tutte le immagini(1)

Documenti

L0595000

Lidocaine

European Pharmacopoeia (EP) Reference Standard

Sinonimo/i:

2-Diethylamino-N-(2,6-dimethylphenyl)acetamide, Lignocaine, Xylocaine

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Tutte le immagini(1)

About This Item

Formula empirica (notazione di Hill):
C14H22N2O
Numero CAS:
137-58-6
Peso molecolare:
234.34
Numero MDL:
MFCD00026733
Codice UNSPSC:
41116107
ID PubChem:
329817367
NACRES:
NA.24

Grado

pharmaceutical primary standard

Famiglia di API

lidocaine

Produttore/marchio commerciale

EDQM

tecniche

HPLC: suitable
gas chromatography (GC): suitable

applicazioni

pharmaceutical (small molecule)

Formato

neat

Stringa SMILE

CCN(CC)CC(=O)Nc1c(C)cccc1C

InChI

1S/C14H22N2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4/h7-9H,5-6,10H2,1-4H3,(H,15,17)
NNJVILVZKWQKPM-UHFFFAOYSA-N

Informazioni sul gene

human ... SCN10A(6336) , SCN11A(11280) , SCN1A(6323) , SCN2A(6326) , SCN3A(6328) , SCN4A(6329) , SCN5A(6331) , SCN7A(6332) , SCN8A(6334) , SCN9A(6335)

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Categorie correlate

Descrizione generale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Applicazioni

Lidocaine EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Azioni biochim/fisiol

Na+ channel blocker; class IB antiarrhythmic that is rapidly absorbed after parenteral administration.

Confezionamento

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Altre note

Sales restrictions may apply.

Prodotti correlati

N° Catalogo
Descrizione
Determinazione del prezzo

1366002

Lidocaine, United States Pharmacopeia (USP) Reference Standard

L0600000

Lidocaine hydrochloride, European Pharmacopoeia (EP) Reference Standard

PHR1257

Lidocaine hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1669

Lidocaine Related Compound A, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1671

Lidocaine Related Compound C, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1673

Lidocaine Related Compound H, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1670

Lidocaine Related Compound B, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1672

Lidocaine Related Compound E, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1674

Lidocaine Related Compound I, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1675

Lidocaine Related Compound J, Pharmaceutical Secondary Standard; Certified Reference Material

1366080

Lidocaine Related Compound H, United States Pharmacopeia (USP) Reference Standard

1366013

Lidocaine hydrochloride, United States Pharmacopeia (USP) Reference Standard

BP727

Lidocaine, British Pharmacopoeia (BP) Reference Standard

BP214

Lidocaine hydrochloride, British Pharmacopoeia (BP) Reference Standard

PHR1995

Lidocaine Impurity G, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1994

Lidocaine Impurity F, Pharmaceutical Secondary Standard; Certified Reference Material

Pittogrammi

Exclamation mark
GHS07

Avvertenze

Warning

Indicazioni di pericolo

H302

Consigli di prudenza

P301 + P312 + P330

Classi di pericolo

Acute Tox. 4 Oral

Codice della classe di stoccaggio

11 - Combustible Solids

Classe di pericolosità dell'acqua (WGK)

WGK 3

Punto d’infiammabilità (°F)

Not applicable

Punto d’infiammabilità (°C)

Not applicable

Choose from one of the most recent versions:

Certificati d'analisi (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Servizio Clienti

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

I clienti hanno visto anche

Slide 1 of 4

1 of 4

Lidocaine hydrochloride Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1257

Lidocaine hydrochloride

Lidocaine hydrochloride monohydrate solid

Sigma-Aldrich

L5647

Lidocaine hydrochloride monohydrate

USP

USP

1605512

Ropivacaine Related Compound A

Propofol European Pharmacopoeia (EP) Reference Standard

Y0000016

Propofol

Song-Young Park et al.
American journal of physiology. Heart and circulatory physiology, 307(3), H346-H352 (2014-06-08)
Unlike cardiac and skeletal muscle, little is known about vascular smooth muscle mitochondrial respiration. Therefore, the present study examined mitochondrial respiratory rates in smooth muscle of healthy human feed arteries and compared with that of healthy cardiac and skeletal muscles.
Bartholomeus C M Benno Haarman et al.
Brain, behavior, and immunity, 40, 219-225 (2014-04-08)
The "monocyte-T-cell theory of mood disorders" regards neuroinflammation, i.e. marked activation of microglia, as a driving force in bipolar disorder. Microglia activation can be visualized in vivo using [(11)C]-(R)-PK11195 PET. Indirect evidence suggests the hippocampus as a potential focus of
Daniela Casoni et al.
Veterinary anaesthesia and analgesia, 42(3), 250-259 (2014-07-22)
To determine the potency ratio between S-ketamine and racemic ketamine as inductive agents for achieving tracheal intubation in dogs. Prospective, randomized, 'blinded', clinical trial conducted in two consecutive phases. 112 client-owned dogs (ASA I or II). All animals were premedicated
Faith A Bazley et al.
IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society, 22(5), 953-964 (2014-05-08)
The adult central nervous system is capable of significant reorganization and adaptation following neurotrauma. After a thoracic contusive spinal cord injury (SCI) neuropathways that innervate the cord below the epicenter of injury are damaged, with minimal prospects for functional recovery.
Barbara Steblaj et al.
Veterinary anaesthesia and analgesia, 41(6), 583-591 (2014-08-08)
To compare pulmonary function and gas exchange in ponies during maintenance of anaesthesia with isoflurane or by a total intravenous anaesthesia (TIVA) technique. Experimental, cross-over study. Six healthy ponies weighing mean 286 (range 233-388) ± SD 61 kg, age 13
Visualizza tutti i documenti correlati

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.